Regenerative Orthopedics and Sports Medicine   Report issue

Academic/Hospital Phase 1
Founded: Washington D.C. United States (2014)

Organization Overview

First Clinical Trial
2019
NCT04241354
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Regenerative Orthopedics and Sports Medicine

Active Ingredients

Drugs in Phase 1 Trials (1)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 1)

Osteoarthritis, Hip (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1